Elemental Diet Regulates Intestinal Permeability and Antibody Production in Indomethacin-Induced Intestinal Injury Rats

Abstract

Crohn's disease is a type of inflammatory bowel disease of unknown etiology. Administration of indomethacin (Indo) to rats induces acute mucosal lesions similar to those observed in Crohn's disease patients, but the damage can be prevented by feeding the animals an elemental diet (ED). In this study, we examined changes in intestinal macroscopic appearance, permeability, and immunoglobulin production after administration of Indo to male Sprague-Dawley rats fed normal lab chow or an ED. Intestinal damage was induced by subcutaneous injection of Indo on two successive days. Mucosal permeability, as measured by urinary excretion of phenolsulfonphthalein, peaked on day 2 after Indo injection, whereas the most severe intestinal damage, as scored by macroscopic inflammatory changes, was observed on day 3. Flow cytometric analysis of mesenteric lymph node cells revealed that the proportion of CD45RA 1 cells was increased after Indo treatment. Furthermore, in vitro-cultured mesenteric lymph node and spleen lymphocytes from Indotreated rats produced higher levels of IgA and IgG than did cells from vehicle-treated rats. In contrast, IgG and albumin concentrations in plasma were significantly decreased by Indo administration. Notably, none of the Indo-induced changes was observed in ED-fed rats. These findings suggest that an ED may prevent the appearance of Indo-induced mucosal lesions, at least in part, by modulating intestinal permeability and antibody production.

Food, gut barrier dysfunction, and related diseases: A new target for future individualized disease prevention and management

“…Caco-2 and HT-29/B6 cells and prevent pro-inflammatory TNFα and TJ dysfunction T-cells response to enteric bacteria ➔ ↑mucosal 5-HT & dopamine, & ↓ tissue 5-HT & NE ➔ related to CNS disorder (+) Low FODMAP diet, Mediterranean diet, Gluten-free diet (especially for HLA-DQ2/8 positive IBD patients), Green tea, Probiotics, Prebiotics, Vitamin D, folic acid, Zinc, Glutamine, Dietary fibers (to produce SCFAs), Psyllium (↓severity of UC), Ginger (especially for Crohn's), Red wine extract (-) High FODMAP diet, Gluten (mainly HLA-DQ2/8-positive Crohn's patients), Processed food including dietary emulsifiers,Food rich in ω−6FA, NSAIDs (Crohn's), Antibiotics (Crohn's), Smoking (Crohn's)Arrieta et al (2009), Bancil et al (2021,Beguin et al (2013),Cordain et al (2000),DeMeo et al (2002),Fukui (2016),Guagnozzi et al (2012),Hossen et al (2020),Kikuchi et al (2019),Kim, Keogh, and Clifton (2018), Lacerda et al (2021), Li et al (2019), Llewellyn et al (2018), Luettig et al (2016), Magnuson et al (2016), Malíčková et al (2017), McAllister et al (2019), Michielan and D'Incà (2015), Nanayakkara et al (2016), Neish (2009), Nunes et al (2019), Sasson et al (2021), Scaldaferri et al (2013), Shin and Lim (2020), Van Buiten et al (2018), Vazquez-Roque et al (2013), Weaver and Herfarth (2021), Yeoh et al (2013), Yoon et al (2018) with HLA) & diet (Food triggers or aggravates 2/3 of IBS patients.) ➔ ↑serum Zonulin level ➔ ↑Serum TNF-α, IL-1β, IL-6 ➔↑epithelial permeability ➔ lowgrade intestinal inflammation.…”